Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Teva
Fish and Richardson
UBS
Julphar
Moodys
US Department of Justice
Chubb
Queensland Health

Generated: December 19, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PRAMLINTIDE ACETATE

« Back to Dashboard

Clinical Trials for Pramlintide Acetate

Trial ID Title Status Sponsor Phase Summary
NCT00042458 Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control Completed AstraZeneca Phase 3 This is a randomized, triple-blind, placebo-controlled, multicenter study to investigate the safety of pramlintide treatment using pramlintide dose-titration coupled with insulin adjustments in subjects with type 1 diabetes who are actively trying to improve their glycemic control.
NCT00042471 Evaluation of the Bioavailability of Pramlintide Completed AstraZeneca Phase 2 This is a randomized, open-label, crossover study to examine the bioavailability of pramlintide in normal weight and overweight subjects with type 1 and type 2 diabetes mellitus using insulin.
NCT00042601 Evaluation of the Effect of Pramlintide on Satiety and Food Intake Completed AstraZeneca Phase 2 This is a single center, randomized, blinded, placebo-controlled, two-period, cross-over study to evaluate the effect of pramlintide on satiety and food intake in normal-weight and obese non-diabetic subjects and in insulin-treated subjects with type 1 and type 2 diabetes.
NCT00044707 Evaluation of an Orally Administered Medication When Taken in Conjunction With Pramlintide Completed AstraZeneca Phase 2 This is a randomized, single-blind, placebo-controlled, crossover study to examine the effect of pramlintide on the pharmacokinetics of an orally administered medication
NCT00107107 Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completed AstraZeneca Phase 3 This is a multicenter, open-label extension study designed to examine the long-term safety of pramlintide treatment in subjects with type 1 diabetes who have successfully completed treatment in the parent study 137-150.
NCT00108004 Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus Completed AstraZeneca Phase 3 This open-label, multicenter study is designed to investigate the clinical utility and safety of pramlintide treatment in subjects with type 1 and type 2 diabetes who are failing to achieve the desired level of glycemic control using insulin therapy.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Pramlintide Acetate

Condition Name

Condition Name for Pramlintide Acetate
Intervention Trials
Obesity 5
Type 1 Diabetes Mellitus 5
Diabetes Mellitus, Type 1 4
Overweight 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Pramlintide Acetate
Intervention Trials
Diabetes Mellitus 11
Diabetes Mellitus, Type 1 10
Diabetes Mellitus, Type 2 7
Body Weight 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Pramlintide Acetate

Trials by Country

Trials by Country for Pramlintide Acetate
Location Trials
United States 207
Australia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Pramlintide Acetate
Location Trials
Texas 12
Florida 12
Oregon 11
California 11
Ohio 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Pramlintide Acetate

Clinical Trial Phase

Clinical Trial Phase for Pramlintide Acetate
Clinical Trial Phase Trials
Phase 4 3
Phase 3 3
Phase 2 9
[disabled in preview] 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Pramlintide Acetate
Clinical Trial Phase Trials
Completed 18
Withdrawn 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Pramlintide Acetate

Sponsor Name

Sponsor Name for Pramlintide Acetate
Sponsor Trials
AstraZeneca 16
Amylin Pharmaceuticals, LLC. 3
Juvenile Diabetes Research Foundation 2
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Pramlintide Acetate
Sponsor Trials
Industry 19
Other 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Julphar
AstraZeneca
Citi
Cipla
Chubb
Johnson and Johnson
US Army
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.